These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2643772)

  • 1. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.
    Turpie AG; Robinson JG; Doyle DJ; Mulji AS; Mishkel GJ; Sealey BJ; Cairns JA; Skingley L; Hirsh J; Gent M
    N Engl J Med; 1989 Feb; 320(6):352-7. PubMed ID: 2643772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of left ventricular mural thrombus.
    Turpie AG
    Am J Cardiol; 1989 Jul; 64(4):41B-43B. PubMed ID: 2750674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean-term calcium heparin treatment in acute transmural anterior myocardial infarction: effects on left ventricular thrombosis and its complications.
    Iacono A
    Cardiologia; 1997 Dec; 42(12):1251-5. PubMed ID: 9534319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose heparin in the prevention of thrombotic complications following acute myocardial infarction.
    Zawilska K; Psuja P; Lewandowski K; Wróz M
    Cor Vasa; 1989; 31(3):179-85. PubMed ID: 2670447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Left ventricular mural thrombus in acute anterior myocardial infarct].
    Silva Oropeza E; Nava López G; Hernández Pétriz J; Tudón Garcés H
    Arch Inst Cardiol Mex; 1986; 56(4):333-8. PubMed ID: 2945528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Carter C; Hirsh J; Genton E; Gent M; Turpie G; McLaughlin D
    N Engl J Med; 1982 Jan; 306(4):189-94. PubMed ID: 7033782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Left ventricular mural thrombi in myocardial infarction in echocardiographic studies and clinical observations].
    Sobkowicz-Woźniak B; Wala A; Wrabec K; Kowalisko A
    Kardiol Pol; 1989; 32(5):259-65. PubMed ID: 2635238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography.
    Asinger RW; Mikell FL; Elsperger J; Hodges M
    N Engl J Med; 1981 Aug; 305(6):297-302. PubMed ID: 7242633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
    Sandset PM; Dahl T; Stiris M; Rostad B; Scheel B; Abildgaard U
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():25-33. PubMed ID: 1962901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Leyvraz PF; Richard J; Bachmann F; Van Melle G; Treyvaud JM; Livio JJ; Candardjis G
    N Engl J Med; 1983 Oct; 309(16):954-8. PubMed ID: 6621623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
    N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
    Hull RD; Raskob GE; Pineo GF; Green D; Trowbridge AA; Elliott CG; Lerner RG; Hall J; Sparling T; Brettell HR
    N Engl J Med; 1992 Apr; 326(15):975-82. PubMed ID: 1545850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
    Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L
    N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.
    Koopman MM; Prandoni P; Piovella F; Ockelford PA; Brandjes DP; van der Meer J; Gallus AS; Simonneau G; Chesterman CH; Prins MH
    N Engl J Med; 1996 Mar; 334(11):682-7. PubMed ID: 8594426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). STEP-Study Group.
    Pezzuoli G; Neri Serneri GG; Settembrini P; Coggi G; Olivari N; Buzzetti G; Chierichetti S; Scotti A; Scatigna M; Carnovali M
    Int Surg; 1989; 74(4):205-10. PubMed ID: 2560470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
    Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS
    Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
    Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis.
    Clark-Pearson DL; DeLong E; Synan IS; Soper JT; Creasman WT; Coleman RE
    Obstet Gynecol; 1990 Apr; 75(4):684-9. PubMed ID: 2179782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.